Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidaemia.

Barnett AH, Mackin P, Chaudhry I, Farooqi A, Gadsby R, Heald A, Hill J, Millar H, Peveler R, Rees A, Singh V, Taylor D, Vora J, Jones PB.

J Psychopharmacol. 2007 Jun;21(4):357-73. Review. Erratum in: J Psychopharmacol. 2008 Aug;22(6):699.

PMID:
17656425
2.

Schizophrenia, antipsychotics and metabolic disease.

Reynolds GP.

J Psychopharmacol. 2007 Jun;21(4):355-6. No abstract available.

PMID:
17656424
3.

Metabolic complications of schizophrenia and antipsychotic medications--an updated review.

Yogaratnam J, Biswas N, Vadivel R, Jacob R.

East Asian Arch Psychiatry. 2013 Mar;23(1):21-8. Review.

4.

[Metabolic side effects of risperidone in early onset schizophrenia].

Goeb JL, Marco S, Duhamel A, Kechid G, Bordet R, Thomas P, Delion P, Jardri R.

Encephale. 2010 Jun;36(3):242-52. doi: 10.1016/j.encep.2009.10.008. Epub 2009 Dec 1. French.

PMID:
20620267
5.

[Schizophrenia and antipsychotics associated with the metabolic syndrome. An overview].

Scheepers-Hoeks AM, Wessels-Basten SJ, Scherders MJ, Bravenboer B, Loonen AJ, Kleppe RT, Grouls RJ.

Tijdschr Psychiatr. 2008;50(10):645-54. Review. Dutch.

6.

[Drawing up guidelines for the attendance of physical health of patients with severe mental illness].

Saravane D, Feve B, Frances Y, Corruble E, Lancon C, Chanson P, Maison P, Terra JL, Azorin JM; avec le soutien institutionnel du laboratoire Lilly.

Encephale. 2009 Sep;35(4):330-9. doi: 10.1016/j.encep.2008.10.014. Epub 2009 Jul 9. French.

PMID:
19748369
7.

Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia.

Casey DE, Haupt DW, Newcomer JW, Henderson DC, Sernyak MJ, Davidson M, Lindenmayer JP, Manoukian SV, Banerji MA, Lebovitz HE, Hennekens CH.

J Clin Psychiatry. 2004;65 Suppl 7:4-18; quiz 19-20. Review. No abstract available.

8.

Physical health in schizophrenia: a challenge for antipsychotic therapy.

Heald A.

Eur Psychiatry. 2010 Jun;25 Suppl 2:S6-11. doi: 10.1016/S0924-9338(10)71700-4. Review.

PMID:
20620888
9.

[Metabolic risk during antipsychotic treatment in patients with schizophrenia].

Rzewuska M.

Psychiatr Pol. 2007 Jul-Aug;41(4):457-72. Review. Polish.

PMID:
18046977
10.
11.

Which comes first: atypical antipsychotic treatment or cardiometabolic risk?

Stahl SM, Mignon L, Meyer JM.

Acta Psychiatr Scand. 2009 Mar;119(3):171-9. doi: 10.1111/j.1600-0447.2008.01334.x. Review.

PMID:
19178394
12.

Metabolic comorbidity in schizophrenia.

Jacob R, Chowdhury AN.

Indian J Med Sci. 2008 Jan;62(1):23-31. Review.

PMID:
18239269
13.

Development of a health screening clinic.

Millar HL.

Eur Psychiatry. 2010 Jun;25 Suppl 2:S29-33. doi: 10.1016/S0924-9338(10)71703-X.

PMID:
20620883
14.

Metabolic risk during antipsychotic treatment.

Newcomer JW.

Clin Ther. 2004 Dec;26(12):1936-46. Review.

PMID:
15823759
15.

Metabolic issues in patients with severe mental illness.

Citrome L, Blonde L, Damatarca C.

South Med J. 2005 Jul;98(7):714-20. Review.

PMID:
16108240
16.

Management of schizophrenia with obesity, metabolic, and endocrinological disorders.

Monteleone P, Martiadis V, Maj M.

Psychiatr Clin North Am. 2009 Dec;32(4):775-94. doi: 10.1016/j.psc.2009.08.003. Review.

PMID:
19944883
17.

Abnormalities of glucose metabolism associated with atypical antipsychotic drugs.

Newcomer JW.

J Clin Psychiatry. 2004;65 Suppl 18:36-46. Review.

18.

[Metabolic syndrome in patients with schizophrenia and antipsychotic treatment].

Aguilar E, Coronas R, CaixĂ s A.

Med Clin (Barc). 2012 Nov 17;139(12):542-6. doi: 10.1016/j.medcli.2012.05.028. Epub 2012 Jul 28. Review. Spanish.

PMID:
22841467
19.

Nursing care of clients treated with atypical antipsychotics who have a risk of developing metabolic instability and/or type 2 diabetes.

Edward KL, Rasmussen B, Munro I.

Arch Psychiatr Nurs. 2010 Feb;24(1):46-53. doi: 10.1016/j.apnu.2009.04.009. Epub 2009 Aug 6. Review.

PMID:
20117688
20.

[Antipsychotic prescription assessment in general practice: metabolic effects].

Gignoux-Froment F, de Montleau F, Saravane D, Verret C.

Encephale. 2012 Dec;38(6):453-9. doi: 10.1016/j.encep.2011.12.006. Epub 2012 Jan 23. French.

PMID:
23200610

Supplemental Content

Support Center